Autologní transplantace s podáním interleukinu aktivovaného štěpu periferních kmenových buněk nemocných s chronickou myeloidní leukémií
| Title in English | Autologous transplantation using interleukin 2 activated peripheral blood stem cell graft in chronical myeloid leukemia patient |
|---|---|
| Authors | |
| Year of publication | 2000 |
| Type | Article in Periodical |
| Magazine / Source | Klinická onkologie |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Description | Efficacyd a protocol of adoptive immunotherapy using IL-2 activated autologous graft followed with IL-2 and GM-CSF immunotherapy was investigated. Interleukin 2 (IL-2) can generate cytotoxic effectors like Natural Killer (NK) cells. Protocol was activated in patients with chronic myeloid leukemia, in which tratment response can be monitored on molecular level and immunotherapy plays fundamental role in the tratment. |
| Related projects: |